| Mankind Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543904 |
NSE Symbol : MANKIND |
P/E(TTM) : 48.82 |
|
ISIN Demat : INE634S01028 |
Div & Yield% : 0.00 |
EPS(TTM) : 42.80 |
|
Book Value(₹) : 375.73 |
Market Cap(₹Cr) : 86,263.88 |
Face Value(₹) : 1.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 2,632.68 | 2,608.78 | 2,541.36 | 2,126.59 | 2,414.41 | 2,544.18 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 2,632.68 | 2,608.78 | 2,541.36 | 2,126.59 | 2,414.41 | 2,544.18 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 56.52 | 77.67 | 64.22 | 219.32 | 70.37 | 139.47 |
| Total Income | 2,689.20 | 2,686.45 | 2,605.58 | 2,345.91 | 2,484.78 | 2,683.65 |
| Total Expenditure | 1,937.85 | 1,915.59 | 1,868.29 | 1,649.67 | 1,668.31 | 1,780.69 |
| PBIDT | 751.35 | 770.86 | 737.29 | 696.24 | 816.47 | 902.96 |
| Interest | 138.37 | 147.20 | 146.70 | 162.25 | 200.27 | 2.61 |
| PBDT | 612.98 | 623.66 | 590.59 | 533.99 | 616.20 | 900.35 |
| Depreciation | 107.69 | 99.03 | 96.93 | 105.24 | 91.11 | 90.33 |
| Tax | 121.56 | 97.54 | 92.14 | 93.07 | 135.85 | 132.42 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -65.74 | -31.81 | -11.24 | -46.78 | -22.78 | 32.26 |
| Reported Profit After Tax | 449.47 | 458.90 | 412.76 | 382.46 | 412.02 | 645.34 |
| Extra-ordinary Items | -63.35 | 0.00 | 0.00 | 0.00 | 0.00 | 31.99 |
| Adjusted Profit After Extra-ordinary item | 512.82 | 458.90 | 412.76 | 382.46 | 412.02 | 613.35 |
| EPS (Unit Curr.) | 10.89 | 11.12 | 10.00 | 9.27 | 10.35 | 16.11 |
| EPS (Adj) (Unit Curr.) | 10.89 | 11.12 | 10.00 | 9.27 | 10.35 | 16.11 |
| Calculated EPS (Unit Curr.) | 10.89 | 11.12 | 10.00 | 9.27 | 10.29 | 16.11 |
| Calculated EPS (Adj) (Unit Curr.) | 10.89 | 11.12 | 10.00 | 9.27 | 10.29 | 16.11 |
| Calculated EPS (Ann.) (Unit Curr.) | 43.55 | 44.47 | 40.02 | 37.08 | 41.14 | 64.44 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 43.55 | 44.47 | 40.02 | 37.08 | 41.14 | 64.44 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 100.00 | 100.00 | 0.00 | 0.00 | 0.00 |
| Equity | 41.28 | 41.28 | 41.26 | 41.26 | 40.06 | 40.06 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 28.54 | 29.55 | 29.01 | 32.74 | 33.82 | 35.49 |
| PBDTM(%) | 23.28 | 23.91 | 23.24 | 25.11 | 25.52 | 35.39 |
| PATM(%) | 17.07 | 17.59 | 16.24 | 17.98 | 17.07 | 25.37 |